HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Awan, M. Articles by Gottlob, I. Search for Related Content PubMed PubMed Citation Articles by Awan, M. Articles by Gottlob, I.

A Randomized Controlled Trial of Unilateral Strabismic and Mixed Amblyopia Using Occlusion Dose Monitors to Record Compliance

From the Department of Ophthalmology, University of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom.

PURPOSE. To investigate compliance with patching therapy and the dose–effect relationship in occlusion therapy in amblyopia by recording the effective patching time using occlusion dose monitors (ODMs).

METHODS. Fifty-two children with strabismic or mixed amblyopia (Snellen equivalent, 6/12–6/48) were given optimal refractive correction and randomly allocated for 12 weeks into three treatment groups: group 1, no patching; group 2, prescribed patching for 3 hours; and group 3, prescribed patching for 6 hours. The effective time of occlusion was monitored with ODMs continuously. Visual acuity (VA) was measured every 3 weeks with LogMAR (logarithm of the minimum angle of resolution) Crowded Tests.

RESULTS. In the 3- and 6-hour groups, mean (SD) compliance was 57.5% (30.8%) and 41.2% (30.9%), respectively, and mean effective patching time per day was 1 hour 43 minutes (55 minutes) and 2 hours 33 minutes (1 hour 52 minutes), respectively. The mean (SD) improvement in logMAR VA of amblyopic eyes was 0.24 (0.17), 0.29 (0.14), and 0.34 (0.19) in groups 1, 2, and 3, respectively. There was no significant difference in compliance with the prescribed patching between the 3- and 6-hour groups. VA outcomes in the 3- and 6-hour groups were not significantly better than 0-hour patching. However, the VA of patients with eyes effectively patched for more than 3 hours improved significantly. A dose–effect relationship was observed. Age at treatment did not influence the visual outcome.

CONCLUSIONS. Poor compliance with prescribed occlusion explains discrepancies in previous studies. No differences in the effect between the different prescribed patching periods were found. The dose–effect relationship observed should encourage development of methods such as educational intervention to improve visual outcome by increasing effective patching time.

This article has been cited by other articles:

				R. W. Li, A. Provost, and D. M. Levi Extended Perceptual Learning Results in Substantial Recovery of Positional Acuity and Visual Acuity in Juvenile Amblyopia Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5046 - 5051. [Abstract] [Full Text] [PDF]

				C. E Stewart, D. A Stephens, A. R Fielder, M. J Moseley, and ROTAS Cooperative Objectively monitored patching regimens for treatment of amblyopia: randomised trial BMJ, October 6, 2007; 335(7622): 707 - 707. [Abstract] [Full Text] [PDF]

				C. E. Stewart, D. A. Stephens, A. R. Fielder, M. J. Moseley, and on behalf of the MOTAS Cooperative Modeling Dose-Response in Amblyopia: Toward a Child-Specific Treatment Plan Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2589 - 2594. [Abstract] [Full Text] [PDF]

				K. A. Arnoldi Current Recommendations for Amblyopia Treatment Amer. Orthoptic Jrnl., January 1, 2007; 57(1): 60 - 67. [Abstract] [PDF]

				S. E. Loudon, M. Fronius, C. W. N. Looman, M. Awan, B. Simonsz, P. J. van der Maas, and H. J. Simonsz Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4393 - 4400. [Abstract] [Full Text] [PDF]

				M Dixon-Woods, M Awan, and I Gottlob Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study Arch. Dis. Child., June 1, 2006; 91(6): 491 - 494. [Abstract] [Full Text] [PDF]